Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells.
Women with triple negative breast cancer (TNBC) have poor prognosis compared to other breast cancer subtypes. There were several reports indicating racial disparity in breast cancer outcomes between African American (AA) and European American (EA) women. For example, the mortality rates of AA breast...
Main Authors: | Shuping Yin, Vino T Cheryan, Liping Xu, Arun K Rishi, Kaladhar B Reddy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5560738?pdf=render |
Similar Items
-
Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins
by: Chanjuan Zheng, et al.
Published: (2021-06-01) -
Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
by: So-Yeon Park, et al.
Published: (2019-07-01) -
Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer
by: Huizhi Sun, et al.
Published: (2019-06-01) -
CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
by: Wang Y, et al.
Published: (2018-09-01) -
New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
by: Noura Khaled, et al.
Published: (2019-04-01)